13 C NMR spectroscopy is a unique tool to measure the cerebral tricarboxylic acid (TCA) cycle rate in vivo. The measurement relies on metabolic modeling of glutamate C3 and C4 enrichment time courses during a 13 C-glucose intravenous infusion. Usual metabolic models require the plasma glucose and 13 Cglucose time courses as input functions, as well as the knowledge of Michaelis-Menten kinetics parameters governing passage through the blood-brain barrier. It is shown in the present work that, when using an infusion protocol yielding a rapidly stable plasma glucose fractional enrichment, metabolic modeling can be simplified in such a manner that this additional information on input function and glucose transport is no longer required, significantly simplifying the measurement of cerebral TCA cycle rate in vivo. 13 C NMR spectroscopy combined with metabolic modeling is a unique tool to measure tricarboxylic acid (TCA) cycle rate in vivo (1,2). The measurement relies on the intravenous infusion of a 13 C-enriched substrate, typically glucose labeled at C1 and/or C6, and on the detection by NMR spectroscopy of the progressive incorporation of 13 C at glutamate C3 and C4 positions. These measured enrichments are related to the TCA cycle flux (V TCA ) using a metabolic model, which is a set of differential equations describing the temporal evolution of 13 C enrichments, depending on the concentration and enrichment time courses of the infused substrates and on metabolic parameters such as fluxes and transport kinetics. In particular, the passage of glucose through the blood-brain barrier and the amount of 13 C-glucose available inside the brain are calculated based on (i) assumed values of the MichaelisMenten parameters; and (ii) the time courses of glucose concentration and fractional enrichment (FE), which impose blood sampling throughout the experiment followed by glucose concentration measurement and 13 C enrichment determination. However, the knowledge of Michaelis-Menten parameters is not straightforward since they might vary between species, tissues, and pathologic conditions, such as diabetes (3). In addition, the experimental burden associated with glycemia and 13 C-glucose plasma measurements, which generally require specific processing and acquisition on a high-resolution NMR or mass spectrometer, complicates significantly the already complex 13 C experiment, especially for small animals like mice due to their limited blood volume.In this context, the goal of the present work was to investigate whether the knowledge of experimental plasma glucose and 13 C-glucose time courses, and a parametered description of the blood-brain barrier transport using Michaelis-Menten kinetics, are actually required for the determination of V TCA by 13 C NMR spectroscopy. It is demonstrated that, under experimental conditions where an adequate infusion protocol yields a rapidly and reasonably stable plasma glucose FE, the FE of the brain pyruvate/lactate pool as simulated using metabolic modeling rapidly reaches a plateau and...